Story · Medicine & Biotech

Biogen to share long-term trial results for its Alzheimer’s drugs

1 outlet · first reported by Longevity.Technology 12d ago

Coverage, in order

  1. 12d ago
    Longevity.Technology UK indie study randomized trial
    Biogen to share long-term trial results for its Alzheimer’s drugs

    Biogen will present new data across its Alzheimer’s disease portfolio at the 19th Clinical Trials on Alzheimer’s Disease conference, 16–19 November 2026, in Boston. Presentations will include expanded results from the Phase 2 CELIA study of diranersen (BIIB080), with a late-breaking symposium…

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.